This inhibition allows ultraviolet-induced DNA damage and reactive oxygen species to accumulate within keratinocytes; hence, overexpression of AHR may contribute to the development of non-melanoma skin cancers. This evidence concerns the gene AHR and non-melanoma skin carcinoma.